Key Takeaways
- In 2021, about 9.2 million people ages 12 and older misused prescription pain relievers in the past year according to NSDUH data
- Approximately 2.7 million people had an opioid use disorder (OUD) in 2021 involving prescription pain relievers
- From 1999–2020, nearly 564,000 people died from overdoses involving prescription opioids
- Males aged 18-25 had highest prescription opioid misuse rate of 5.6% in 2021
- Females represented 52% of prescription opioid overdose deaths in 2020
- Adults aged 35-54 had the highest rates of prescription opioid use disorder at 1.5% in 2019
- Overdose death rates from prescription opioids highest in 25-44 age group at 14.5 per 100k
- Prescription opioid misuse linked to 152,000 overdose deaths 1999-2019
- Neonatal opioid withdrawal syndrome affected 7 per 1,000 births in 2017
- 40% of OUD patients relapse within 1 month of treatment
- Medication-assisted treatment (MAT) with buprenorphine reduces mortality 50%
- Only 1 in 10 OUD patients receive medications like methadone
- Annual economic cost of prescription opioid misuse $78.5 billion in 2013
- Opioid crisis cost US $1.02 trillion 2015-2020 including healthcare
- Lost productivity from prescription OUD $23.7 billion yearly
Millions misuse prescription drugs despite declining rates and deadly consequences.
Costs
Costs Interpretation
Demographics
Demographics Interpretation
Health Effects
Health Effects Interpretation
Prevalence
Prevalence Interpretation
Treatment
Treatment Interpretation
Sources & References
- Reference 1NIDAnida.nih.govVisit source
- Reference 2SAMHSAsamhsa.govVisit source
- Reference 3CDCcdc.govVisit source
- Reference 4JAMANETWORKjamanetwork.comVisit source
- Reference 5NCBIncbi.nlm.nih.govVisit source
- Reference 6WONDERwonder.cdc.govVisit source
- Reference 7NEJMnejm.orgVisit source
- Reference 8PEDIATRICSpediatrics.aappublications.orgVisit source
- Reference 9BMJbmj.comVisit source
- Reference 10ASPEaspe.hhs.govVisit source
- Reference 11COUNCILOFECONOMICADVISORScouncilofeconomicadvisors.govVisit source
- Reference 12OIGoig.hhs.govVisit source
- Reference 13SSAssa.govVisit source






